India Host Cell Protein Testing Market Research Report Data Analysis by Product Type, by End User Forecast to 2032

Description

List of Tables

India Host Cell Protein Testing Market Research Report Data Analysis by Product Type (PCR-based assays, ELISA-based assays, mass spectrometry-based assays and others), by End User (Contract Research Organizations, Biopharmaceutical Companies, and Others) Forecast to 2032

Market Overview

It is anticipated that the India Host Cell Protein Testing Market will experience a robust CAGR of 99.12% during the review period. During the manufacturing of biotherapeutics, the host organism generates host cell proteins (HCPs), which are process-related impurities. Many HCPs are eliminated from the final product during the purification procedure. They are proteins that are either produced or encoded by the organisms that produce recombinant therapeutic proteins. Cell culture/fermentation technology is typically employed to produce recombinant therapeutic proteins from genetically modified prokaryotic or eukaryotic host cells.

The India host cell protein market is being driven by the high demand for biologics in India and the increasing adoption of stringent regulatory guidelines for biopharmaceutical production in the country. Nevertheless, it is anticipated that the Indian market's expansion will be impeded by the efficiency and precision of the test tools. However, the Indian market is being presented with lucrative opportunities because of the increasing number of start-ups and government initiatives associated with the biopharmaceutical industry in India.

Market Segmentation

The India host cell protein testing market has been segmented into PCR-based assays, ELISA-based assays, mass spectrometry-based assays, and others, based on product type. Mass Spectrometry-Based Assays is the fastest-growing segment during the forecast period, which spans from 2023 to 2032, while the ELISA-Based Assays segment held the largest market share in 2022.

The India host cell protein testing market has been segmented into contract research organizations, biopharmaceutical companies, and others based on End User.

Major Players

Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Enzo Life Sciences, Inc., Cytiva, Cygnus Technologies, LLC, Rockland Immunochemicals, Inc, Biogenes GmbH, and Krishgen BioSystems are the primary players in the Indian host cell protein testing market.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 HIGH DEMAND FOR BIOLOGICS ACROSS THE INDIA
- 4.2.2 RISING ADOPTION OF STRINGENT REGULATORY GUIDELINES FOR BIOPHARMACEUTICAL PRODUCTION
4.3 RESTRAINTS
- 4.3.1 ISSUES RELATED TO THE EFFICIENCY AND ACCURACY OF THE TEST KITS
4.4 OPPORTUNITY
- 4.4.1 GROWING GOVERNMENT INITIATIVES AND INCREASING START-UPS ASSOCIATED WITH BIOPHARMACEUTICAL INDUSTRY

ACROSS THE INDIA 34

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE INDIA HOST CELL PROTEIN MARKET

6 INDIA HOST CELL PROTEIN MARKET, BY TYPE

6.1 OVERVIEW

7 INDIA HOST CELL PROTEIN MARKET, BY END USER

7.1 OVERVIEW

8 COMPETITIVE LANDSCAPE

8.1 INTRODUCTION
8.2 MARKET SHARE ANALYSIS, 2022
8.3 COMPETITOR DASHBOARD
8.4 PUBLIC PLAYERS STOCK SUMMARY
8.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

9 COMPANY PROFILES

9.1 ENZO LIFE SCIENCES, INC
- 9.1.1 COMPANY OVERVIEW
- 9.1.2 FINANCIAL OVERVIEW
- 9.1.3 PRODUCTS OFFERED
- 9.1.4 KEY DEVELOPMENTS
- 9.1.5 SWOT ANALYSIS
- 9.1.6 KEY STRATEGIES
9.2 BIO-RAD LABORATORIES, INC
- 9.2.1 COMPANY OVERVIEW
- 9.2.2 FINANCIAL OVERVIEW
- 9.2.3 PRODUCTS OFFERED
- 9.2.4 KEY DEVELOPMENTS
- 9.2.5 SWOT ANALYSIS
- 9.2.6 KEY STRATEGIES
9.3 ABCAM LIMITED
- 9.3.1 COMPANY OVERVIEW
- 9.3.2 FINANCIAL OVERVIEW
- 9.3.3 PRODUCTS OFFERED
- 9.3.4 KEY DEVELOPMENTS
- 9.3.5 KEY STRATEGIES
9.4 THERMO FISHER SCIENTIFIC INC
- 9.4.1 COMPANY OVERVIEW
- 9.4.2 FINANCIAL OVERVIEW
- 9.4.3 PRODUCTS OFFERED
- 9.4.4 KEY DEVELOPMENTS
- 9.4.5 SWOT ANALYSIS
- 9.4.6 KEY STRATEGY
9.5 CYTIVA
- 9.5.1 COMPANY OVERVIEW
- 9.5.2 FINANCIAL OVERVIEW
- 9.5.3 PRODUCTS OFFERED
- 9.5.4 KEY DEVELOPMENTS
- 9.5.5 SWOT ANALYSIS
- 9.5.6 KEY STRATEGIES
9.6 CYGNUS TECHNOLOGIES, LLC
- 9.6.1 COMPANY OVERVIEW
- 9.6.2 FINANCIAL OVERVIEW
- 9.6.3 PRODUCTS OFFERED
- 9.6.4 KEY DEVELOPMENTS
- 9.6.5 KEY STRATEGY
9.7 AGILENT TECHNOLOGIES, INC
- 9.7.1 COMPANY OVERVIEW
- 9.7.2 FINANCIAL OVERVIEW
- 9.7.3 PRODUCTS OFFERED
- 9.7.4 KEY DEVELOPMENTS
- 9.7.5 SWOT ANALYSIS
- 9.7.6 KEY STRATEGIES
9.8 ROCKLAND IMMUNOCHEMICALS, INC
- 9.8.1 COMPANY OVERVIEW
- 9.8.2 FINANCIAL OVERVIEW
- 9.8.3 PRODUCTS/SERVICES OFFERED
- 9.8.4 KEY DEVELOPMENTS
- 9.8.5 KEY STRATEGIES
9.9 BIOGENES GMBH
- 9.9.1 BIOGENES GMBH
- 9.9.2 FINANCIAL OVERVIEW
- 9.9.3 PRODUCTS OFFERED
- 9.9.4 KEY DEVELOPMENTS
- 9.9.5 KEY STRATEGIES
9.10 KRISHGEN BIOSYSTEMS
- 9.10.1 COMPANY OVERVIEW
- 9.10.2 FINANCIAL OVERVIEW
- 9.10.3 PRODUCTS OFFERED
- 9.10.4 KEY DEVELOPMENTS
- 9.10.5 KEY STRATEGIES

10 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 INDIA HOST CELL PROTEIN MARKET, BY TYPE, 2019-2032 (USD MILLION)
TABLE 3 INDIA HOST CELL PROTEIN MARKET, BY MASS SPECTROMETRY-BASED ASSAYS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 4 INDIA HOST CELL PROTEIN MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 5 PUBLIC PLAYERS STOCK SUMMARY
TABLE 6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 7 ENZO LIFE SCIENCES, INC: PRODCUTS OFFERED
TABLE 8 BIO-RAD LABORATORIES, INC: PRODCUTS OFFERED
TABLE 9 ABCAM LIMITED: PRODCUTS OFFERED
TABLE 10 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
TABLE 11 CYTIVA: PRODCUTS OFFERED
TABLE 12 CYGNUS TECHNOLOGIES, LLC: PRODCUTS OFFERED
TABLE 13 AGILENT TECHNOLOGIES, INC: PRODUCT OFFERED
TABLE 14 ROCKLAND IMMUNOCHEMICALS, INC: PRODUCTS OFFERED
TABLE 15 BIOGENES GMBH: PRODUCTS OFFERED
TABLE 16 KRISHGEN BIOSYSTEMS: PRODCUTS OFFERED
TABLE 17 KRISHGEN BIOSYSTEMS: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 INDIA HOST CELL PROTEIN MARKET: STRUCTURE
FIGURE 2 INDIA HOST CELL PROTEIN MARKET REPORT: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: INDIA HOST CELL PROTEIN MARKET
FIGURE 6 INDIA HOST CELL PROTEIN MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)
FIGURE 7 INDIA HOST CELL PROTEIN MARKET, BY TYPE, 2022 & 2032 (USD MILLION)
FIGURE 8 INDIA HOST CELL PROTEIN MARKET SHARE (%), BY TYPE, 2022
FIGURE 9 INDIA HOST CELL PROTEIN MARKET, END USER SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION)
FIGURE 10 INDIA HOST CELL PROTEIN MARKET, BY END USER, 2022 & 2032 (USD MILLION)
FIGURE 11 INDIA HOST CELL PROTEIN MARKET SHARE (%), BY END USER, 2022
FIGURE 12 INDIA HOST CELL PROTEIN MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 13 COMPETITOR DASHBOARD: INDIA HOST CELL PROTEIN MARKET
FIGURE 14 ENZO LIFE SCIENCES, INC: SWOT ANALYSIS
FIGURE 15 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS
FIGURE 17 ABCAM LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
FIGURE 20 CYTIVA: SWOT ANALYSIS
FIGURE 21 AGILENT TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 AGILENT TECHNOLOGIES, INC: SWOT ANALYSIS